Evidence map›Paper›PMID 39011648›Full record

ArticleNanomedicine (London, England)2024

Enhanced biosafety, anticancer and antibacterial photodynamic activities using silver-pyropheophorbide-a nanoconjugates.

Tabbisa Namulinda, Zhi-Bing Song, Yi-Jia Yan, Min Zhang, Gennady A Meerovich, Davor Margetic, Zhi-Long Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tabbisa NamulindaDepartment of Pharmaceutical Science & Technology, Donghua University, Shanghai 201620, China.ORCID 0000-0002-0374-7500
Zhi-Bing SongDepartment of Pharmaceutical Science & Technology, Donghua University, Shanghai 201620, China.
Yi-Jia YanDepartment of Pharmacy, Huadong Hospital, Fudan University, Shanghai 200040, China.
Min ZhangDepartment of Pharmacy, Huadong Hospital, Fudan University, Shanghai 200040, China.
Gennady A MeerovichGeneral Physics Institute of Russian Academy of Sciences, Moscow 119435, Russia.
Davor MargeticRudjer Boskovic Institute, Zagreb 10000, Croatia.
Zhi-Long ChenDepartment of Pharmaceutical Science & Technology, Donghua University, Shanghai 201620, China.ORCID 0000-0001-9716-8368

Funding

Foundation of Shanghai Science and Technology Committee 21430730100, 21MC1930200, 23S11901600Grant of Fudan University IDF163011International Corporation Grant of the Ministry of Science, Technology of China 9-11National Natural Science Foundation of China 22361132541RSF grant 24-45-00020Zhongguancun Precision Medicine Foundation ZGC-YXKJ-25
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsChlorophyllEscherichia coliNanoconjugatesPhotochemotherapyPhotosensitizing AgentsReactive Oxygen SpeciesSilverAnimalsCell Line, TumorCell SurvivalHumansMetal NanoparticlesMiceNeoplasmsAnti-Bacterial AgentsAntineoplastic AgentsChlorophyllNanoconjugatesPhotosensitizing Agentspyropheophorbide aReactive Oxygen SpeciesSilverAntibacterialcancernanoconjugatesphotodynamic therapypyropheophorbide-a

Identifiers

PMID39011648
PMCPMC11389735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.